Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Appili Therapeutics, Halifax, NS, Canada.
Front Immunol. 2023 Sep 15;14:1238391. doi: 10.3389/fimmu.2023.1238391. eCollection 2023.
is the etiological agent of the potentially severe infection tularemia. An existing vaccine, the live vaccine strain (LVS), has been used to protect at-risk personnel, but it is not licensed in any country and it has limited efficacy. Therefore, there is a need of a new, efficacious vaccine. The aim of the study was to perform a detailed analysis of the characteristics of the human immune response to , since this will generate crucial knowledge required to develop new vaccine candidates. Nine individuals were administered the LVS vaccine and peripheral blood mononuclear cells (PBMC) were collected before and at four time points up to one year after vaccination. The properties of the PBMC were characterized by flow cytometry analysis of surface markers and intracellular cytokine staining. In addition, the cytokine content of supernatants from -infected PBMC cultures was determined and the protective properties of the supernatants investigated by adding them to cultures with infected monocyte-derived macrophages (MDM). Unlike before vaccination, PBMC collected at all four time points after vaccination demonstrated -specific cell proliferation, cytokine secretion and cytokine-expressing memory cells. A majority of 17 cytokines were secreted at higher levels by PBMC collected at all time points after vaccination than before vaccination. A discriminative analysis based on IFN-γ and IL-13 secretion correctly classified samples obtained before and after vaccination. Increased expression of IFN-γ, IL-2, and MIP-1β were observed at all time points after vaccination vs. before vaccination and the most significant changes occurred among the CD4 transient memory, CD8 effector memory, and CD8 transient memory T-cell populations. Growth restriction of the highly virulent strain SCHU S4 in MDM was conferred by supernatants and protection correlated to levels of IFN-γ, IL-2, TNF, and IL-17. The findings demonstrate that vaccination induces long-term T-cell reactivity, including T and T cell populations. Individual cytokine levels correlated with the degree of protection conferred by the supernatants. Identification of such memory T cells and effector mechanisms provide an improved understanding of the protective mechanisms against . mechanisms against .
是潜在严重感染土拉热的病原体。现有的活疫苗株(LVS)已被用于保护高危人群,但它在任何国家都没有获得许可,而且效果有限。因此,需要一种新的、有效的疫苗。本研究的目的是对人类对的免疫反应特征进行详细分析,因为这将产生开发新疫苗候选物所需的关键知识。9 名个体接种了 LVS 疫苗,并在接种前和接种后 4 个时间点(长达 1 年)采集外周血单核细胞(PBMC)。通过流式细胞术分析表面标志物和细胞内细胞因子染色来表征 PBMC 的特性。此外,还测定了来自感染 PBMC 培养物的上清液中的细胞因子含量,并通过将上清液添加到感染的单核细胞衍生巨噬细胞(MDM)培养物中来研究上清液的保护特性。与接种前相比,接种后所有 4 个时间点采集的 PBMC 均表现出对的特异性细胞增殖、细胞因子分泌和表达细胞因子的记忆细胞。与接种前相比,接种后所有时间点采集的 PBMC 分泌的 17 种细胞因子中有多数细胞因子水平更高。基于 IFN-γ和 IL-13 分泌的判别分析正确地将接种前和接种后的样本分类。与接种前相比,接种后所有时间点观察到 IFN-γ、IL-2 和 MIP-1β的表达增加,最显著的变化发生在 CD4 短暂记忆、CD8 效应记忆和 CD8 短暂记忆 T 细胞群中。在 MDM 中,高毒力株 SCHU S4 的生长受到上清液的限制,保护与 IFN-γ、IL-2、TNF 和 IL-17 的水平相关。研究结果表明,接种可诱导长期的 T 细胞反应,包括 T 和 T 细胞群。个体细胞因子水平与上清液赋予的保护程度相关。鉴定这种记忆 T 细胞和效应机制提供了对的保护机制的更好理解。